1-241504246-C-T
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PVS1_StrongPM2PP5_Very_Strong
The NM_000143.4(FH):c.905-1G>A variant causes a splice acceptor, intron change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000143.4 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FH | NM_000143.4 | c.905-1G>A | splice_acceptor_variant, intron_variant | Intron 6 of 9 | ENST00000366560.4 | NP_000134.2 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Canonical splice site variant expected to result in aberrant splicing, although in the absence of functional evidence the actual effect of this sequence change is unknown.; Not observed at significant frequency in large population cohorts (Lek 2016); This variant is associated with the following publications: (PMID: 27535533, 15761418, 20301430, 20618355, 17908262, 15663510, 19939761, 25525159) -
This variant is not present in population databases (gnomAD no frequency). This sequence change affects an acceptor splice site in intron 6 of the FH gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in FH are known to be pathogenic (PMID: 11865300, 21398687). Disruption of this splice site has been observed in individual(s) with hereditary leiomyomatosis and renal cell carcinoma (HLRCC) (PMID: 15761418). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 208374). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. -
Fumarase deficiency Pathogenic:1
- -
Hereditary cancer-predisposing syndrome Pathogenic:1
The c.905-1G>A intronic pathogenic mutation results from a G to A substitution one nucleotide upstream from coding exon 7 of the FH gene. In one study, this mutation was identified in four Iranian families with multiple cutaneous and uterine leiomyomas, and haplotype analysis suggested this alteration may represent a founder mutation (Chuang GS et al. J. Am. Acad. Dermatol. 2005 Mar;52:410-6). In silico splice site analysis predicts that this alteration will weaken the native splice acceptor site and will result in the creation or strengthening of a novel splice acceptor site. In addition to the clinical data presented in the literature, alterations that disrupt the canonical splice site are expected to cause aberrant splicing, resulting in an abnormal protein or a transcript that is subject to nonsense-mediated mRNA decay. As such, this alteration is classified as a disease-causing mutation. -
Hereditary leiomyomatosis and renal cell cancer Other:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at